Jade Biosciences, Inc.
JBIO
$13.66
-$0.32-2.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 69.00% | -9.97% | 342.51% | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 415.60% | 20.23% | 163.48% | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 73.23% | -9.70% | 339.78% | ||
|
|
|||||
| Total Current Assets | 73.23% | -9.70% | 339.78% | ||
| Net Property, Plant & Equipment | -2.18% | -0.87% | 20.78% | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -60.34% | 190.00% | -98.76% | ||
| Total Assets | 72.77% | -9.61% | 297.64% | ||
|
|
|||||
| Total Accounts Payable | 74.88% | -83.79% | 79.98% | ||
| Total Accrued Expenses | -10.41% | 53.38% | 6.93% | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | -- | 38.84% | 74.49% | ||
| Total Other Current Liabilities | -- | 38.84% | 74.49% | ||
| Total Current Liabilities | -26.02% | 3.41% | 34.71% | ||
|
|
|||||
| Total Current Liabilities | -26.02% | 3.41% | 34.71% | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -3.08% | -5.68% | 1.15% | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | -25.28% | 3.09% | -83.97% | ||
|
|
|||||
| Common Stock & APIC | 57.49% | 0.91% | 19,366.54% | ||
| Retained Earnings | -22.42% | -21.47% | -37.74% | ||
| Treasury Stock & Other | 344.83% | 220.83% | -- | ||
| Total Common Equity | 85.40% | -11.02% | 341.36% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | 85.40% | -11.02% | 341.36% | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 85.41% | -11.02% | 341.36% | ||
|
|
|||||